Fluorinated anthracyclines: interactions with DNA
- PMID: 2084069
- DOI: 10.1007/BF00198591
Fluorinated anthracyclines: interactions with DNA
Abstract
Four fluorine containing derivatives of anthracyclines (daunomycin and adriamycin) were synthesised, and comprised C-13, 1,1,1-trifluoroethyl-hydrazones of each anthracycline, and C-14 4-F and 4-CF3-benzoate esters of adriamycin. All four derivatives intercalated into DNA in a manner similar to their parent anthracycline. The ester derivatives exhibited 3-4-fold higher binding affinity to DNA, and slower DNA dissociation kinetics than adriamycin. This stabilisation derives from additional contacts of the C-14 side chain to the DNA minor groove. The hydrazone derivatives showed lower binding affinity to DNA, and dissociated from DNA 3-4 times faster than the parent compound. The 19F resonance of the bound drug was broadened to 120 Hz and shifted 60 Hz downfield (0.32 ppm) relative to the sharp (7.5 Hz) peak of the free drug. These values imply a rapid exchange between the free and DNA bound forms (DNA lifetime greater than 5 ms), with the fluorine group residing in a hydrophobic region in close contact with the DNA minor groove. The 4-8 fold lesser specific potency of the ester derivatives supports the concept that DNA binding is an important factor, but not sole determinant of biological activity of these analogues.
Similar articles
-
Fluorinated anthracyclines: synthesis and biological activity.Invest New Drugs. 1990 Feb;8(1):1-6. doi: 10.1007/BF00216918. Invest New Drugs. 1990. PMID: 2345065
-
Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.J Med Chem. 1997 Apr 11;40(8):1276-86. doi: 10.1021/jm960835d. J Med Chem. 1997. PMID: 9111302
-
Interaction of new derivatives of daunorubicin and adriamycin with DNA.Farmaco Sci. 1977 May;32(5):315-23. Farmaco Sci. 1977. PMID: 862886
-
Sequence specificity in the binding of anti-tumour anthracyclines to DNA: a success of theory.Anticancer Drug Des. 1991 May;6(2):95-105. Anticancer Drug Des. 1991. PMID: 2039585 Review.
-
Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.J Clin Pharmacol. 1986 Sep-Oct;26(7):491-509. doi: 10.1002/j.1552-4604.1986.tb02942.x. J Clin Pharmacol. 1986. PMID: 2944917 Review.
Cited by
-
Bis-daunomycin hydrazones: interactions with DNA.Invest New Drugs. 1992 Jul;10(2):79-88. doi: 10.1007/BF00873121. Invest New Drugs. 1992. PMID: 1500269